SurgiQ makes clinical care processes more effective, less invasive and easier on patients, their families and healthcare teams by achieving targets and allowing priority-based scheduling for both cancer and non-cancer patients.
SurgiQ provides real-time tracking and Artificial Intelligence tools with the ability for dynamic reporting and planning of the patient’s entire care assessment journey; from GP referral to post-treatment hospital discharge.
We have created transparent processes, designed to meet patients', providers' and commissioners' needs. We are deeply committed in collecting evidence and enhancing gold-standards and best practice.
SurgiQ and Barts have piloted solutions to prioritise, streamline and audit surgical care plan processes, on cancer and non-cancer patients. The SurgiQ dashboards allow live tracking of waiting times, breaches, demand for surgery, clinical outcomes, service effectiveness and efficiency.
Staff surveys indicate that SurgiQ is user friendly and tracks the progress of patient care plan processes, giving real time access to vital information for the scheduling and planning of pre-assessments and theatre; assisting with the prevention of security breaches. The study also estimated an increase in efficiency and time saving.
Barts Health NHS Trust, Queen Mary University London, and SurgiQ are working together to deliver a novel multi-specialty audit system to monitor the impact of the robotic surgery program at the Royal London Hospital. General availability of the solution to other Trusts is expected for Q2 2020.
At Galliera Hospital in Genoa, SurgiQ manages surgical waiting lists and pre-admission processes in a trackable, integrated and collaborative manner.
The SurgiQ platform allows sharing, of all relevant information regarding patient care plan processes in real-time with team members (i.e. surgeons, anaesthetists, nurses, admin); here SurgiQ has notably improved process management. Patient’s rights are protected by SurgiQ’s unique prioritisation algorithm, allowing the correct activities and scheduling according to the patient’s clinical urgency categories and waiting times.
At Galliera Hospital, a reference regional hospital for elderly care medicine, SurgiQ provides live support to better integrate primary with secondary care either in elective or post-discharge settings.
SurgiQ has also contributed to the design and delivery of a new care model supporting a nurse-managed ward, reducing costs, and optimising bed occupancy and patient outflow across all different levels of care.
Bambino Gesù is the largest paediatric hospital and medical research centre in Europe, with connections to several leading international centres across the sector and a staff of nearly 3,300 members.
The adoption of SurgiQ has introduced several benefits, including a fully paperless computer-based waiting list and centralised pre-admission management system, thereby improving patient guarantee in terms of integrity and transparency.
All actions and relevant information is tracked, and processed data is audited. The SurgiQ prioritisation system is now a shared tool, helping staff to schedule patients for surgery.
SurgiQ has an Information Security Management System certified by RINA in compliance with the standard ISO/IEC 27001:2013 in designing and delivering software solutions in the healthcare market.
"SurgiQ s.r.l." (hereinafter, "SurgiQ") is an health-tech startup based in Genoa - Italy, Via Venti Settembre 33 and tax number ID IT02395170992.
"SurgiQ Ltd" is our legal entity registered in England and Wales, at 520 Birchwood Boulevard, Birchwood, Warrington, WA3 7QX and VAT GB322994093.
The site www.surgiq.com (hereinafter, "Website") and its content (text, images, sounds, animations, films, graphics, brands, trademarks, logos, audiovisual content, etc.) are the exclusive property of SurgiQ and are protected by current legislation and standards on the protection of trademarks, copyright, etc. (Law of April 22, 1941, no. 633 – hereinafter, "LdA"). In relation to this content, the reproduction, communication to the public, rental and loan, public execution, even partial, and unauthorized distribution by SurgiQ are prohibited. Any breaches will be subject to the sanctions specified by Articles. 171, 171-bis, 171-ter, 174-bis and 174-ter of this LdA. The content may be subject to technological protection measures in accordance with Arts. 102-quater and following of the LdA.
The reproduction, on any support, of the materials published in this Website, where expressly permitted, may be carried out, in any case, for exclusively personal use, provided this is done without profit purposes and direct or indirect commercial purposes, in accordance with any technological protection measures.
This Website contains links to other Internet sites, which are not under the control of SurgiQ; the publication of these links on the Website does not mean that SurgiQ approves or backs these sites or their content; nor is it any form of guarantee or responsibility on the part of SurgiQ.
The information on this web site is for your general information only. Information you read on this web site cannot replace the relationship that you have with your health care professional and is not intended to affect that relationship in any way. SurgiQ does not practice medicine or provide medical services or advice and the information on this web site should not be considered medical advice. You should always talk to your health care professional for diagnosis and treatment. Health information changes quickly. Therefore, it is always best to confirm information with your health care professional.
The content available on the Website is not tech, health, or economics advice in any form and does not in any way replace the necessary advice and specific tech and health assistance.